Rick Heaslip is the Founder of Programmatic Sciences, a consultancy specializing in the optimization of organizational program management capabilities. He is also a faculty member in Organizational Dynamics at the Univ. of Penn. He was formerly VP of Project and Portfolio Management at Wyeth.
Charles Gombar, Endo Pharmaceuticals Holdings Inc, United States
Dr. Gombar is currently Senior Vice President of Project Management at Endo Pharmaceuticals. Dr. Gombar received his undergraduate degree in Chemistry from Pace University and his Ph.D. in Pharmacology from the Albany Medical College.
Description
The biopharmaceutical industry has been employing novel drug development models in order to bring new drugs to the market in a timely and cost-effective manner. This showcase will address the impact of these changes on the discipline of pharmaceutical project management. The core competencies for the pharmaceutical project manager of the future will be described. Developed by the Project Management (PM) SIAC.
Learning Objectives: Discuss the history of project management in the biopharmaceutical industry Identify project management competencies of the future Recognize the impact of new drug development models on project managers.